title,chinese_title,category,original_publish_date,publish_date,summary,chinese_summary,original_file_url,source_url
TRS 1060 - Annex 6: Guideline on bioanalytical method validation and study sample analysis,生物分析方法验证与研究样品分析指南,Development,15 April 2025,2025-04-15,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/annex-6_guideline-on-bioanalytical-method-validation-and-study-sample-analysis.pdf?sfvrsn=4fc96250_3&download=true,https://www.who.int/publications/m/item/trs-1060---annex-6--guideline-on-bioanalytical-method-validation-and-study-sample-analysis
TRS 970 - Annex 3: Pharmaceutical development of multisource (generic) finished pharmaceutical products: points to consider,多源（仿制）成品药的药品开发：需考虑的要点,Development,30 October 2012,2012-10-30,,,https://cdn.who.int/media/docs/default-source/medicines/annex3trs-970.pdf?sfvrsn=4cb3b2ec_7&download=true,https://www.who.int/publications/m/item/pharmaceutical-development-of-multisource-(generic)
TRS 970 - Annex 5: Development of paediatric medicines: points to consider in formulation,儿科药物的开发：制剂中需考虑的要点,Development,31 December 2011,2011-12-31,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs970/annex5trs-970.pdf?sfvrsn=699cdb68_8&download=true,https://www.who.int/publications/m/item/trs970-annex-5-development-of-paediatric-medicines-points-to-consider-in-formulation
TRS 1060 - Annex 4: Good practices for blood establishments,血液机构的良好实践,Production,15 April 2025,2025-04-15,This document is intended to provide guidance to blood establishment managers and staff on ensuring the quality and safety of blood and blood components for transfusion and plasma for further industrial fractionation.,本文旨在为血液机构的管理者和工作人员提供指导，以确保用于输注的血液和血液成分以及用于进一步工业分离的血浆的质量和安全。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/annex-4_good-practices-for-blood-establishments.pdf?sfvrsn=a5cbb34c_5&download=true,https://www.who.int/publications/m/item/trs-1060---annex-4--good-practices-for-blood-establishments
TRS 1060 - Annex 3: WHO good manufacturing practices for excipients used in pharmaceutical products,WHO药品用辅料的GMP,Production,15 April 2025,2025-04-15,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/annex-3_who-good-manufacturing-practices-for-excipients-used-in-pharmaceutical-products.pdf?sfvrsn=44922c56_3&download=true,https://www.who.int/publications/m/item/trs-1060---annex-3--who-good-manufacturing-practices-for-excipients-used-in-pharmaceutical-products
TRS 1060 - Annex 2: WHO good practice considerations for the prevention and control of nitrosamines in pharmaceutical products,WHO关于药品中亚硝胺类物质预防与控制的GMP考虑因素,Production,15 April 2025,2025-04-15,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/annex-2_who-good-practice-considerations-for-the-prevention-and-control-of-nitrosamines-in-pharmaceutical-products.pdf?sfvrsn=fac9d7d8_5&download=true,https://www.who.int/publications/m/item/trs-1060---annex-2--who-good-practice-considerations-for-the-prevention-and-control-of-nitrosamines-in-pharmaceutical-products
TRS 1052 - Annex 3: IAEA/WHO good manufacturing practices for in house cold kits for radiopharmaceutical preparations,国际原子能机构/WHO 用于放射性药物制剂室内冷藏试剂盒的GMP,Production,26 April 2024,2024-04-26,This text has been developed in alignment with the International Atomic Energy Agency and World Health Organization guideline on good manufacturing practices for radiopharmaceutical products (1) and IAEA/WHO guideline on good manufacturing practices for investigational radiopharmaceutical products (2).,本文根据国际原子能机构和世界卫生组织关于放射性药物产品GMP的指南（1），以及IAEA/WHO关于研究用放射性药物产品GMP的指南（2）制定。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1052_annex3.pdf?sfvrsn=67707539_4&download=true,https://www.who.int/publications/m/item/trs-1052---annex-3--iaea-who-good-manufacturing-practices-for-in-house-cold-kits-for-radiopharmaceutical-preparations
TRS 1052 - Annex 2: WHO good manufacturing practices for excipients used in pharmaceutical products,WHO药品中使用的辅料GMP,Production,26 April 2024,2024-04-26,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1052_annex2.pdf?sfvrsn=4729bcf0_6&download=true,https://www.who.int/publications/m/item/trs-1052---annex-2--who-good-manufacturing-practices-for-excipients-used-in-pharmaceutical-products
TRS 1044 - Annex 5: WHO good manufacturing practices for medicinal gases,WHO药品气体GMP,Production,14 November 2022,2022-11-14,"Arising from an increased demand for medicinal gases, in particular the  use of oxygen in the treatment of patients with coronavirus disease 2019  (COVID-19), the World Health Organization (WHO) Health Products  Policy and Standards Department (formerly Essential Medicines and Health  Products) and other departments involved in the supply of oxygen and the  inspection of production sites of medicinal gases raised the urgency for the  preparation of the WHO good manufacturing practices for medicinal gases  guidance text.",鉴于对医用气体需求的增加，尤其是氧气在2019冠状病毒病（COVID-19）患者治疗中的广泛应用，世界卫生组织（WHO）卫生产品政策与标准司（原基本药物与卫生产品司）及其他参与氧气供应和医用气体生产场所检查的部门，迫切需要编制《WHO医用气体良好生产规范指导文件》。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1044-annex5-good-manufacturing-practices-for-medicinal-gases.pdf?sfvrsn=d273977a_1&download=true,https://www.who.int/publications/m/item/trs1044-annex5
TRS 1044 - Annex 2: WHO good manufacturing practices for sterile pharmaceutical products,WHO 的无菌药品 GMP,Production,31 October 2022,2022-10-31,"This document is a revision of WHO good manufacturing practices for sterile  pharmaceutical products, previously published in the WHO Technical Report  Series, No. 961, Annex 6, 2011.1   The revision was done in collaboration with  the European Union and the Pharmaceutical Inspection Co-operation Scheme  (PIC/S). The harmonized text will benefit the national regulatory authorities  and manufacturers and save resources, thus improving patients’ access to quality  medicines.",本文是对世界卫生组织（WHO）无菌药品GMP的修订版，该版本曾于2011年发表在WHO技术报告系列第961号文件的附件6中。此次修订工作由欧洲联盟与药品检查合作计划（PIC/S）共同完成。统一后的文本将惠及各国监管机构和生产企业，并有助于节约资源，从而提高患者获得优质药品的机会。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1044-annex-2-gmp-for-sterile-pharmaceutical-products.pdf?sfvrsn=d924ed65_1&download=true,https://www.who.int/publications/m/item/trs1044-annex2
TRS 1044 - Annex 6: WHO good practices for research and development facilities of pharmaceutical products,WHO药品研发机构的GMP良好规范,Production,30 September 2022,2022-09-30,"This annex contains the World Health Organization (WHO) and United Nations  Population Fund (UNFPA) technical specification for TCu380A intrauterine  device (IUD), which is suitable for bulk procurement of the TCu380A IUD for  use in public sector programmes for family planning.",本附件包含世界卫生组织（WHO）和联合国人口基金（UNFPA）针对TCu380A宫内节育器（IUD）的技术规范，该规范适用于公共部门计划生育项目的TCu380A IUD批量采购。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1044-annex6-good-practices-for-research-and-dev-facilities-of-pharmaceutical-products.pdf?sfvrsn=e50d092f_3&download=true,https://www.who.int/publications/m/item/trs1044-annex6
TRS 1044 - Annex 7: WHO good manufacturing practices for investigational products,WHO GMP 适用于研究用产品的指南,Production,31 August 2022,2022-08-31,The objective of this update is to bring the guideline in line with current  expectations and trends in good practices and to harmonize the text with the  principles of other related international guidelines.,本次更新的目的是使指南符合当前良好实践的期望和趋势，并与其他相关国际指南的原则保持一致。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1044-annex7-good-manufacturing-practices-for-investigational-products.pdf?sfvrsn=66b15a93_1&download=true,https://www.who.int/publications/m/item/trs1044-annex7
TRS 1044 - Annex 3: IAEA/WHO guideline on good manufacturing practices for investigational,国际原子能机构/WHO关于研究用GMP的指南,Production,31 July 2022,2022-07-31,"In view of the rapidly expanding field of molecular imaging and targeted  radiopharmaceutical therapy, combined with the absence of dedicated guidance  specific to the manufacture of investigational radiopharmaceuticals used in  both early and late clinical trials, the World Health Organization (WHO), in  partnership with the International Atomic Energy Agency (IAEA), has raised the  urgency for the generation of a new IAEA/WHO guideline on good manufacturing  practices for investigational radiopharmaceutical products.",鉴于分子影像和靶向放射性药物治疗领域的快速扩展，加之目前尚缺乏专门针对用于早期和晚期临床试验的研究用放射性药物生产的指导方针，世界卫生组织（WHO）已与国际原子能机构（IAEA）合作，迫切需要制定一份新的IAEA/WHO关于研究用放射性药物产品GMP的指南。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1044-annex3-good-manufacturing-practices-for-radiopharmaceutical-products-(1).pdf?sfvrsn=fa6af369_1&download=true,https://www.who.int/publications/m/item/trs1044-annex3
TRS 1044 - Annex 4: WHO guidelines on technology transfer in pharmaceutical manufacturing,WHO关于药品生产中技术转让的指南,Production,30 April 2022,2022-04-30,"During the fifty-fifth meeting of the World Health Organization Expert Committee  on Specifications for Pharmaceutical Preparations, Expert Committee members  were updated on the annual consultation on good practices for health products  manufacture and inspection, which took place in July 2020 over a series of  virtual meetings due to the COVID-19 pandemic. During these virtual meetings,  a group of experts made a series of proposals for future activities, including a  possible update of the WHO guidelines on transfer of technology in pharmaceutical  manufacturing (1).",在世界卫生组织药品规格专家委员会第五十五次会议期间，专家委员会成员听取了关于2020年7月因新冠疫情而通过一系列线上会议举行的卫生产品生产和检验良好实践年度磋商的最新情况。在这些线上会议上，一组专家就未来活动提出了一系列建议，其中包括可能对世卫组织药品生产技术转让指南进行更新（1）。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1044-annex4-technology-transfer-in-pharmaceutical-manufacturing.pdf?sfvrsn=9a174f1a_1&download=true,https://www.who.int/publications/m/item/trs1044-annex4
TRS 1033 - Annex 3: Good manufacturing practices: water for pharmaceutical use,GMP：制药用水,Production,17 November 2021,2021-11-17,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033-annex3-gmp-water-for-pharmaceuticals-use.pdf?sfvrsn=aaa46ae5_4&download=true,https://www.who.int/publications/m/item/annex-3-trs-1033
TRS 1033 - Annex 4: WHO Guideline on data integrity,WHO GMP 数据完整性指南,Production,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033-annex4-guideline-on-data-integrity.pdf?sfvrsn=6218a4e6_4&download=true,https://www.who.int/publications/m/item/annex-4-trs-1033
TRS 1033 - Annex 2: Points to consider when including Health-Based Exposure Limits (HBELs) in cleaning validation,在清洁验证中纳入基于健康的暴露限值（HBELs）时需考虑的要点,Production,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033-annex2-points-to-consider-when-incl-hbels-in-cleaning-validation.pdf?sfvrsn=5ee0cd8a_1&download=true,https://www.who.int/publications/m/item/annex-2-trs-1033
TRS 1025 - Annex 2: IAEA - WHO good manufacturing practices for radiopharmaceutical products,国际原子能机构 - WHO 放射性药物产品的 GMP,Production,30 September 2020,2020-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex2.pdf?sfvrsn=7aceb0c1_6&download=true,https://www.who.int/publications/m/item/trs1025-annex2
TRS 1025 - Annex 3: Production of water for injection by means other than distillation,采用蒸馏法以外的方法生产注射用水,Production,20 April 2020,2020-04-20,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex3.pdf?sfvrsn=caebed51_4&download=true,https://www.who.int/publications/m/item/trs-1025-annex-3-water-for-injection
TRS 1025 - Annex 6: Points to consider for manufacturers and inspectors: environmental aspects of manufacturing for the prevention of antimicrobial resistance,制造商和检查员需考虑的要点：为预防抗菌素耐药性而进行生产的环境因素,Production,20 April 2020,2020-04-20,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex6.pdf?sfvrsn=c947184b_2&download=true,https://www.who.int/publications/m/item/trs-1025-annex-6
"TRS 1019 - Annex 2: WHO good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical products (part 2): interpretation of guidelines",WHO非无菌药品加热、通风与空调系统GMP（第二部分）：指南解读,Production,30 September 2019,2019-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/who-good-manufacturing-practices-for-heating-ventilation-and-air-conditioning-systems-for-non-sterile-pharmaceutical-products-(part-2)-interpretation-of-guidelines.pdf?sfvrsn=88f312c7_3&download=true,https://www.who.int/publications/m/item/trs1019-annex2
TRS 1019 - Annex 3: Good manufacturing practices: guidelines on validation,GMP：验证指南,Production,25 January 2019,2019-01-25,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1019-annex3-gmp-validation.pdf?sfvrsn=9440a5c_0&download=true,https://www.who.int/publications/m/item/trs1019-annex3
"TRS 1010 - Annex 8: Guidelines on heating, ventilation and air-conditioning systems for non-sterile pharmaceutical products",非无菌药品的加热、通风与空调系统指南,Production,10 October 2018,2018-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1010-annex8-who-gmp-heating-ventilation-airconditioning.pdf?sfvrsn=c77698e2_0&download=true,https://www.who.int/publications/m/item/Annex-8-trs-1010
TRS 1010 - Annex 2: WHO good manufacturing practices for the manufacture of herbal medicines,WHO草药药品生产的GMP,Production,30 September 2018,2018-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1010-annex2-who-gmp-manufacture-herbal-medicines.pdf?sfvrsn=9241812_0&download=true,https://www.who.int/publications/m/item/trs1010-annex2
TRS 1010 - Annex 1: WHO good manufacturing practices for the manufacture of herbal medicines,WHO 草药生产的 GMP,Production,30 September 2018,2018-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1010-annex1-herbal-processing.pdf?sfvrsn=80b60ae5_0&download=true,https://www.who.int/publications/m/item/trs1010-annex1
TRS 996 - Annex 3: WHO good manufacturing practices for biological products (jointly with the Expert Committee on Biological Standardization),WHO 生物制品 GMP（与生物标准化专家委员会联合制定）,Production,14 April 2016,2016-04-14,"This current revision reflects subsequent developments that have taken place in science and technology, and in theapplication of risk-based approaches to GMP (2–14). The content of this document should be considered complementary      to the general recommendations set out in the current WHO good manufacturing practices for pharmaceutical products: main principles (2) and in other WHO documents related specifically to the production and control of biological products.",本次修订反映了科学技术以及基于风险的GMP方法应用方面的最新进展（2–14）。本文件的内容应被视为对现行《WHO药品生产质量管理规范：基本原则》（2）及其他专门针对生物制品生产和质量控制的WHO文件中所载总体建议的补充。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs996-annex03-gmp-for-biological-products.pdf?sfvrsn=b04b05b4_1&download=true,https://www.who.int/publications/m/item/trs996-annex3
TRS 992 - Annex 4: General guidance on hold-time studies,关于留样研究的一般指导,Production,31 October 2015,2015-10-31,"These guidelines focus primarily on aspects that should be considered in the  design of the hold-time studies during the manufacture of non-sterile solid dosage  forms. Many of the principles described here also apply to other dosage forms  such as liquids, creams and ointments. These guidelines do not cover aspects for  hold times in cleaning validation, or the manufacturing of active pharmaceutical  ingredients (APIs) or biologicals.",本指南主要关注非无菌固体剂型生产过程中留样稳定性研究设计中应考虑的各个方面。其中许多原则同样适用于液体、乳膏和软膏等其他剂型。本指南不涉及清洁验证中的留样时间，以及原料药或生物制品的生产相关方面。,https://cdn.who.int/media/docs/default-source/medicines/who-technical-report-series-who-expert-committee-on-specifications-for-pharmaceutical-preparations/trs-992/annex4-trs992.pdf?sfvrsn=4051caf4_2&download=true,https://www.who.int/publications/m/item/trs992-annex4
TRS 986 - Annex 2: WHO good manufacturing practices for pharmaceutical products: Main principles,WHO药品GMP：主要原则,Production,1 October 2014,2014-10-01,"Licensed pharmaceutical products (marketing authorization) should be  manufactured only by licensed manufacturers (holders of a manufacturing  authorization) whose activities are regularly inspected by competent national  authorities. This guide to GMP shall be used as a standard to justify GMP status,  which constitutes one of the elements of the WHO Certification Scheme on the  quality of pharmaceutical products moving in international commerce, through  the assessment of applications for manufacturing authorizations and as a basis  for the inspection of manufacturing facilities. It may also be used as training  material for government medicines inspectors, as well as for production, QC  and QA personnel in the industry",获准上市的药品（上市许可）应仅由获得许可的生产商（持有生产许可的机构）生产，这些企业的活动须定期接受国家主管当局的检查。本GMP指南将用作判定GMP合规性的标准，而GMP合规性正是世界卫生组织（WHO）国际药品贸易质量认证体系的重要组成部分之一，通过评估生产许可申请并作为工厂检查的基础来实现。此外，该指南还可作为政府药品监管人员的培训材料，以及供制药行业中的生产、质量控制和质量保证人员使用。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs986annex2.pdf?sfvrsn=320c9e62_6&download=true,https://www.who.int/publications/m/item/trs986-annex2
TRS 981 - Annex 2: WHO guidelines on quality risk management,WHO关于质量风险管理的指南,Production,25 January 2013,2013-01-25,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs981-annex2-who-quality-risk-management.pdf?sfvrsn=2fa44bc4_2&download=true,https://www.who.int/publications/m/item/trs981-annex2
TRS 961 - Annex 4: WHO good manufacturing practices for blood establishments (jointly with the Expert Committee on Biological Standardization),WHO 血液机构 GMP（与生物标准化专家委员会联合发布）,Production,30 September 2011,2011-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs961-annex4-gmp-blood-establishments.pdf?sfvrsn=bea4fa1b_2&download=true,https://www.who.int/publications/m/item/trs961-annex4
TRS 957 - Annex 2: WHO good manufacturing practices for active pharmaceutical ingredients (bulk drug substances),WHO 原料药 GMP,Production,1 October 2010,2010-10-01,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs957annex2_gmpactivepharmaceuticalingredientstrs_en.pdf?sfvrsn=694cf26_3&download=true,https://www.who.int/publications/m/item/annex-2-trs-957
TRS 957 - Annex 3: WHO good manufacturing practices for pharmaceutical products containing hazardous substances,WHO药品中含危险物质的GMP,Production,30 September 2010,2010-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs957_annex3_who-gmp-for-pharmaceutical-products-containing-hazardous-substances.pdf?sfvrsn=c5602d61_4&download=true,https://www.who.int/publications/m/item/trs957-annex3
TRS 957 - Annex 7: WHO guidelines for the preparation of a contract research organization master file,WHO关于合同研究组织主文件编制的指南,Production,30 September 2010,2010-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs957-annex7-guidelinespreparationcontractresearchorgmasterfile.pdf?sfvrsn=958aef39_2&download=true,https://www.who.int/publications/m/item/trs-957-annex-7
TRS 902 - Annex 9: Guidelines on packaging for pharmaceutical products,药品包装指南,Production,10 October 2002,2002-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs902-annex9.pdf?sfvrsn=82b4c57d_2&download=true,https://www.who.int/publications/m/item/annex-9-trs-902
TRS 1044 - Annex 8: Points to consider for setting the remaining shelf-life of medical products upon delivery,医疗器械产品交付时剩余有效期的设定需考虑的要点,Distribution,20 April 2022,2022-04-20,"Following the publication of Points to consider for setting the remaining shelf-life of  medical products upon delivery in 2020, a group from international agencies and  humanitarian organizations procuring health kits (including the International  Committee of the Red Cross, Médecins Sans Frontières, Save the Children,  United Nations Children’s Fund, United Nations Population Fund and the World  Health Organization) submitted a draft proposal for an amendment to include  emergency health kits used as part of the humanitarian response as an additional  example for consideration.",继2020年发布《关于确定医疗产品交付后剩余有效期的考虑要点》后，来自采购卫生包的国际机构和人道主义组织（包括国际红十字委员会、无国界医生组织、拯救儿童会、联合国儿童基金会、联合国人口基金以及世界卫生组织）的一个小组，提交了一份提案草案，建议增补一项修订内容，将作为人道主义应急响应一部分使用的紧急卫生包列为额外的参考示例。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs1044-annex8-points-to-consider-for-setting-the-remaining-shelf-life-of-medical-products.pdf?sfvrsn=dd30f2ab_2&download=true,https://www.who.int/publications/m/item/trs-1044-annex-8-shelf-life-medical-products-delivery
TRS 1033 - Annex 9: Guidelines on the implementation of the WHO Certification Scheme on the quality of pharmaceutical products moving in international commerce,世界卫生组织（WHO）关于国际药品贸易中药品质量认证计划实施的指南,Distribution,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033_annex9_guidelines-on-implementation-of-cpp.pdf?sfvrsn=c40c033b_1&download=true,https://www.who.int/publications/m/item/annex-9-trs-1033
TRS 986 - Appendix 6: Interagency finished pharmaceutical product questionnaire,跨机构成品药品问卷,Distribution,17 February 2021,2021-02-17,,,https://cdn.who.int/media/docs/default-source/procurement/iapq-template.pdf?sfvrsn=de076515_1&download=true,https://www.who.int/publications/m/item/interagency-finished-pharmaceutical-product-questionnaire
TRS 1025 - Annex 7: Good storage and distribution practices for medical products,医疗产品的良好储存与配送规范,Distribution,17 June 2020,2020-06-17,"Storage and distribution are important activities in the supply chain management of medical products. Various people and entities may be responsible for the handling, storage and distribution of medical products. Medical products may be subjected to various risks at different stages in the supply chain, for example, purchasing, storage, repackaging, relabelling, transportation and distribution.",储存和配送是医疗产品供应链管理中的重要活动。各类人员和实体可能负责医疗产品的搬运、储存和配送工作。在供应链的不同环节，例如采购、储存、重新包装、重新贴标、运输和配送等阶段，医疗产品可能会面临各种风险。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs1025-annex7-(1).pdf?sfvrsn=1f96888d_4&download=true,https://www.who.int/publications/m/item/trs-1025-annex-7
TRS 1019 - Annex 5: Guidelines on import procedures for medical products,医疗产品进口程序指南,Distribution,10 October 2019,2019-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs1019-annex5-who-guidelines-on-import-procedures-for-medical-products.pdf?sfvrsn=ef223e14_2&download=true,https://www.who.int/publications/m/item/annex-5-trs-1019
TRS 1010 - Annex 5: WHO guidance on testing of “suspect” falsified medicines,WHO关于“可疑”假药检测的指导原则,Distribution,30 September 2018,2018-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1010-annex5-testing-suspect-samples.pdf?sfvrsn=df47cb5_2&download=true,https://www.who.int/publications/m/item/trs1010-annex5
TRS 966 - Annex 2: FIP–WHO technical guidelines: Points to consider in the provision by health-care professionals of children-specific preparations that are not available as authorized products,FIP–WHO 技术指南：卫生保健专业人员在提供儿童专用制剂时需考虑的要点，这些制剂并非作为授权产品供应,Distribution,10 October 2016,2016-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs966-annex2-fip---who-technical-guideline.pdf?sfvrsn=efe8e221_2&download=true,https://www.who.int/publications/m/item/annex-2-trs-966
TRS 966 - Annex 7: Guidelines on the conduct of surveys of the quality of medicines,药品质量调查指南,Distribution,10 October 2016,2016-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs966-annex7-who-guidelines-on-the-conduct-of-surveys-of-the-quality-of-medicines.pdf?sfvrsn=4dbb5519_2&download=true,https://www.who.int/publications/m/item/Annex-7-trs-no-966
TRS 996 - Annex 6: WHO good trade and distribution practices for pharmaceutical starting materials,WHO药品原料药良好贸易与分销规范,Distribution,10 October 2016,2016-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs996-annex06-good-trade-and-distribution-practice-for-starting-materials914a3c92-e15d-420d-859a-34f666a6c659.pdf?sfvrsn=71e466ca_2&download=true,https://www.who.int/publications/m/item/annex-6-trs-996
TRS 992 - Annex 5: Technical supplements to Model guidance for the storage and transport of time- and temperature–sensitive pharmaceutical products,技术性补充文件——关于对时间和温度敏感的药品储存与运输的示范指南,Distribution,10 October 2015,2015-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs992-annex545d189fa-afef-4763-8da8-05401b91a128.pdf?sfvrsn=1bfa9db_1&download=true,https://www.who.int/publications/m/item/trs992-annex5
TRS 986 - Annex 4: Assessment tool based on the model quality assurance system for procurement agencies: aide-memoire for inspection,基于采购机构模型质量保证体系的评估工具：检查备忘录,Distribution,10 October 2014,2014-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs986-annex4-assessment-tool-based-on-the-model-quality-assurance-system.pdf?sfvrsn=d4c03f00_7&download=true,https://www.who.int/publications/m/item/annex4-trs986-eng
TRS 986 - Annex 3: WHO model quality assurance system for procurement agencies,WHO采购机构GMP质量保证体系范本,Distribution,30 September 2014,2014-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs986-annex3-who-model-quality-assurance-system-for-procurement-agencies.pdf?sfvrsn=4baca576_4&download=true,https://www.who.int/publications/m/item/trs-986-annex-3
"TRS 961 - Annex 9, Supplement 3: Estimating the capacity of storage facilities",估算仓储设施的容量,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp3.pdf?sfvrsn=4149f0d7_2&download=true,https://www.who.int/publications/m/item/Annex-9-b-trs-961
"TRS 961 - Annex 9, Supplement 12: Temperature-controlled transport operations by road and by air",公路和航空的温控运输作业,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp12.pdf?sfvrsn=c1ce5b05_2&download=true,https://www.who.int/publications/m/item/Annex-9-k-trs-961
"TRS 961 - Annex 9, Supplement 1: Selecting sites for storage facilities",选择仓储设施的地点,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp1.pdf?sfvrsn=30aca9e5_2&download=true,https://www.who.int/publications/m/item/Annex-9-trsno-961
"TRS 961 - Annex 9, Supplement 6: Temperature and humidity monitoring systems for fixed storage areas",固定储存区域的温湿度监测系统,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp6.pdf?sfvrsn=f7bf9011_2&download=true,https://www.who.int/publications/m/item/Annex-9-e-trs-961
"TRS 961 - Annex 9, Supplement 15: Temperature and humidity monitoring systems for transport operations",运输作业的温度和湿度监测系统,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp15.pdf?sfvrsn=cd633a05_2&download=true,https://www.who.int/publications/m/item/Annex-9-n-trs-961
"TRS 961 - Annex 9, Supplement 8: Temperature mapping of storage areas",储存区域的温度测绘,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp8.pdf?sfvrsn=fb423ff8_2&download=true,https://www.who.int/publications/m/item/Annex-9-g-trs-961
"TRS 961 - Annex 9, Supplement 4: Building security and fire protection",建筑安全与消防,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp4.pdf?sfvrsn=d3c6a190_2&download=true,https://www.who.int/publications/m/item/Annex-9-c-trs-961
"TRS 961 - Annex 9, Supplement 13: Qualification of shipping containers",运输容器的确认,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp13.pdf?sfvrsn=bbacf511_2&download=true,https://www.who.int/publications/m/item/Annex-9-l-trs-961
"TRS 961 - Annex 9, Supplement 10: Checking the accuracy of temperature control and monitoring devices",检查温度控制和监测设备的准确性,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp10.pdf?sfvrsn=382d9bb0_2&download=true,https://www.who.int/publications/m/item/Annex-9-i-trs-961
"TRS 961 - Annex 9, Supplement 14: Transport route profiling qualification",运输路线的轮廓资质,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp14.pdf?sfvrsn=3ec45974_2&download=true,https://www.who.int/publications/m/item/Annex-9-m-trs-961
TRS 961 - Annex 9: Introduction to the Technical Supplements,技术补充说明,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9introduction.pdf?sfvrsn=64f4568_2&download=true,https://www.who.int/publications/m/item/Annex-9-trs-no-961
TRS 961 - Annex 8: Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services,FIP/WHO联合药学 GMP 指南：药学服务质量标准,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex8-fipwhoguidelinesgoodpharmacypractice.pdf?sfvrsn=fda75eb_2&download=true,https://www.who.int/publications/m/item/annex-8-trs-961
"TRS 961 - Annex 9, Supplement 11: Qualification of refrigerated road vehicles",冷藏道路车辆的资质认证,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp11.pdf?sfvrsn=d84ca4c8_2&download=true,https://www.who.int/publications/m/item/Annex-9-j-trs-961
"TRS 961 - Annex 9, Supplement 2: Design and procurement of storage facilities",仓储设施的设计与采购,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp2.pdf?sfvrsn=6c33edd1_2&download=true,https://www.who.int/publications/m/item/Annex-9-a-trs-961
"TRS 961 - Annex 9, Supplement 16: Environmental management of refrigeration equipment",制冷设备的环境管理,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp16.pdf?sfvrsn=e528f744_2&download=true,https://www.who.int/publications/m/item/Annex-9-o-trs-961
"TRS 961 - Annex 9, Supplement 9: Maintenance of refrigeration equipment",制冷设备的维护,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp9.pdf?sfvrsn=73c19946_2&download=true,https://www.who.int/publications/m/item/Annex-9-h-trs-961
"TRS 961 - Annex 9, Supplement 7: Qualification of temperature-controlled storage areas",温控储存区域的确认,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp7.pdf?sfvrsn=3c9a94ed_2&download=true,https://www.who.int/publications/m/item/Annex-9-f-trs-961
"TRS 961 - Annex 9, Supplement 5: Maintenance of storage facilities",仓储设施的维护,Distribution,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex9-supp5.pdf?sfvrsn=5f01b8f5_2&download=true,https://www.who.int/publications/m/item/Annex-9-d-trs-961
TRS 961 - Annex 9: Model guidance for the storage and transport of time and temperature sensitive pharmaceutical products,时间和温度敏感型药品储存与运输的模型指南,Distribution,2 August 2011,2011-08-02,"These guidelines set out the principal requirements for the safe storage and distribution of time- and temperature-sensitive pharmaceutical products (TTSPPs). They are based upon existing regulations and best practice guidance from a wide range of international sources, while accepting that local legislation and regulations will continue to take precedence. The target audience includes regulators, logisticians and pharmaceutical professionals in industry, government and the international agencies.",这些指南阐述了对时间和温度敏感的药品（TTSPPs）进行安全储存和配送的主要要求。它们以现有法规以及来自众多国际渠道的最佳实践指导为基础，同时承认地方立法和法规仍将继续优先适用。目标受众包括监管机构、物流人员，以及工业界、政府和国际机构中的制药专业人士。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs961-annex9-modelguidanceforstoragetransport.pdf?sfvrsn=66be1860_2&download=true,https://www.who.int/publications/m/item/trs961-annex9-modelguidanceforstoragetransport
TRS 929 - Annex 4: WHO guidelines for sampling of pharmaceutical products and related materials,WHO药品及相关物料取样指南,Distribution,10 October 2005,2005-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs929-annex4-guidelinessamplingpharmproducts.pdf?sfvrsn=c47a0070_1&download=true,https://www.who.int/publications/m/item/annex-4-trs-929
TRS 917 - Annex 3: WHO pharmaceutical starting materials certification scheme (SMACS): guidelines on implementation,WHO原料药认证计划（SMACS）：实施指南,Distribution,10 October 2003,2003-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs917-annex3-certification-scheme-implementation.pdf?sfvrsn=dbdf5179_2&download=true,https://www.who.int/publications/m/item/annex-3-trs-917
TRS 1025 - Annex 4: WHO good chromatography practices,WHO GMP,Inspections,20 May 2021,2021-05-20,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex4.pdf?sfvrsn=53f56dbc_4&download=true,https://www.who.int/publications/m/item/trs1025-annex4
TRS 1025 - Annex 6: Points to consider for manufacturers and inspectors: environmental aspects of manufacturing for the prevention of antimicrobial resistance,制造商和检查员需考虑的要点：为预防抗菌素耐药性而采取的GMP环境因素,Inspections,20 April 2020,2020-04-20,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex6.pdf?sfvrsn=c947184b_2&download=true,https://www.who.int/publications/m/item/trs-1025-annex-6
TRS 1025 - Annex 5: Quality management system requirements for national inspectorates,国家检查机构的GMP要求,Inspections,20 April 2020,2020-04-20,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex5.pdf?sfvrsn=910c5942_2&download=true,https://www.who.int/publications/m/item/trs-1025-annex-5-qms-national-inspectorates
"TRS 1010 - Annex 9: WHO good practices for desk assessment of compliance with good manufacturing practices, good laboratory practices and good clinical practices for medical products regulatory decisions",WHO药品监管决策中医疗产品GMP、GLP和GCP合规性桌面评估的良好实践,Inspections,30 September 2018,2018-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/trs1010-annex9--desk-assessment.pdf?sfvrsn=3e2b1a_2&download=true,https://www.who.int/publications/m/item/trs1010-annex9
"TRS 996 - Annex 4, Appendix 2: WHO good manufacturing practices inspection: Example of a risk category assessment of the site depending on level of compliance and inspection frequency",WHO GMP检查：根据合规水平和检查频率，对现场进行风险类别评估的示例,Inspections,30 September 2016,2016-09-30,,,https://cdn.who.int/media/docs/default-source/2021-dha-docs/trs996_annex4_appendix2.pdf?sfvrsn=a5183e07_1&download=true,https://www.who.int/publications/m/item/trs996-annex4-appendix2
"TRS 996 - Annex 4, Appendix 1: WHO guidance on good manufacturing practices: Model inspection report",WHO关于GMP的指导：示范检查报告,Inspections,30 September 2016,2016-09-30,,,https://cdn.who.int/media/docs/default-source/2021-dha-docs/trs996_annex4.pdf?sfvrsn=c44d141a_1&download=true,https://www.who.int/publications/m/item/trs996-annex4-appendix1
TRS 992 - Annex 4: General guidance on hold-time studies,关于留样研究的一般指导,Inspections,31 October 2015,2015-10-31,"These guidelines focus primarily on aspects that should be considered in the  design of the hold-time studies during the manufacture of non-sterile solid dosage  forms. Many of the principles described here also apply to other dosage forms  such as liquids, creams and ointments. These guidelines do not cover aspects for  hold times in cleaning validation, or the manufacturing of active pharmaceutical  ingredients (APIs) or biologicals.",本指南主要关注非无菌固体制剂生产过程中留样稳定性研究设计中应考虑的各个方面。其中许多原则同样适用于液体、乳膏和软膏等其他剂型。本指南不涉及清洁验证中的留样时间要求，以及原料药或生物制品的生产相关事宜。,https://cdn.who.int/media/docs/default-source/medicines/who-technical-report-series-who-expert-committee-on-specifications-for-pharmaceutical-preparations/trs-992/annex4-trs992.pdf?sfvrsn=4051caf4_2&download=true,https://www.who.int/publications/m/item/trs992-annex4
TRS 986 - Annex 4: Assessment tool based on the model quality assurance system for procurement agencies: aide-memoire for inspection,基于采购机构模型质量保证体系的评估工具：检查备忘录,Inspections,10 October 2014,2014-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs986-annex4-assessment-tool-based-on-the-model-quality-assurance-system.pdf?sfvrsn=d4c03f00_7&download=true,https://www.who.int/publications/m/item/annex4-trs986-eng
TRS 961 - Annex 14: WHO guidelines for drafting a site master file,WHO起草现场主文件的指南,Inspections,31 October 2011,2011-10-31,The aim of these explanatory notes is to guide the manufacturer of medicinal  products in the preparation of an SMF that is useful to the regulatory  authority in planning and conducting GMP inspections.,本说明旨在指导药品生产商编制一份SMF，以帮助监管机构规划和实施GMP检查。,https://cdn.who.int/media/docs/default-source/medicines/who-technical-report-series-who-expert-committee-on-specifications-for-pharmaceutical-preparations/who-guidelines-for-drafting-a-site-master-filee834ef01-0ebe-400d-9130-daff614884d8.pdf?sfvrsn=89e9986b_1&download=true,https://www.who.int/publications/m/item/trs961-annex14
TRS 961 - Annex 13: WHO guidelines for preparing a laboratory information file,WHO制定实验室信息文件的指南,Inspections,30 September 2011,2011-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs961-annex13-guidelines-preparing-laboratory-information-file.pdf?sfvrsn=54d1f397_2&download=true,https://www.who.int/publications/m/item/trs961-annex13
TRS 957 - Annex 7: WHO guidelines for the preparation of a contract research organization master file,WHO 制定合同研究组织主文件的指南,Inspections,30 September 2010,2010-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs957-annex7-guidelinespreparationcontractresearchorgmasterfile.pdf?sfvrsn=958aef39_2&download=true,https://www.who.int/publications/m/item/trs-957-annex-7
TRS 902 - Annex 7: WHO guidelines on pre-approval inspections,WHO的批准前检查指南,Inspections,30 September 2002,2002-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/trs902-annex7-preapprovalinspections.pdf?sfvrsn=64a91595_2&download=true,https://www.who.int/publications/m/item/trs902-annex7
TRS 823 - Annex 2: Inspection of pharmaceutical manufacturers,药品生产企业的检查,Inspections,30 September 1992,1992-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/trs823-annex2-inspectionpharmaceuticalmanufacturers.pdf?sfvrsn=5d1d785b_2&download=true,https://www.who.int/publications/m/item/trs823-annex2
TRS 1060 - Annex 9: Guidance for the graphic representation of chemical structures of pharmaceutical substances in the publications of International Nonproprietary Names and The International Pharmacopoeia,国际非专利名称和《国际药典》出版物中药品化学结构图形表示指南,Quality control,15 April 2025,2025-04-15,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/annex-9_guidance-for-the-graphic-representation-of-chemical-structures-of-pharmaceutical-substances.pdf?sfvrsn=26d38b7e_3&download=true,https://www.who.int/publications/m/item/trs-1060---annex-9--guidance-for-the-graphic-representation-of-chemical-structures-of-pharmaceutical-substances-in-the-publications-of-international-nonproprietary-names-and-the-international-pharmacopoeia
TRS 1060 - Annex 2: WHO good practice considerations for the prevention and control of nitrosamines in pharmaceutical products,WHO关于药品中亚硝胺类物质预防与控制的GMP考虑因素,Quality control,15 April 2025,2025-04-15,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/annex-2_who-good-practice-considerations-for-the-prevention-and-control-of-nitrosamines-in-pharmaceutical-products.pdf?sfvrsn=fac9d7d8_5&download=true,https://www.who.int/publications/m/item/trs-1060---annex-2--who-good-practice-considerations-for-the-prevention-and-control-of-nitrosamines-in-pharmaceutical-products
TRS 1052 - Annex 5: WHO/UNFPA female condom generic specification,WHO/UNFPA 女性安全套通用规范,Quality control,26 April 2024,2024-04-26,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1052_annex5.pdf?sfvrsn=81780e4d_4&download=true,https://www.who.int/publications/m/item/trs-1052---annex-5--who-unfpa-female-condom-generic-specification
TRS 1052 - Annex 4: WHO good practices for pharmaceutical quality control laboratories,WHO药品质量控制实验室良好规范,Quality control,26 April 2024,2024-04-26,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1052_annex4.pdf?sfvrsn=d3dfc0cc_4&download=true,https://www.who.int/publications/m/item/who-good-practices-for-pharmaceutical-quality-control-laboratories
TRS 1044 - Annex 9: WHO/UNFPA guidance on natural rubber latex male condom stability studies,WHO/UNFPA 关于天然橡胶乳胶男用安全套稳定性研究的指南,Quality control,30 September 2022,2022-09-30,Manufacturers of natural rubber latex male condoms are required by regulatory  bodies to establish the shelf-life of their products prior to placing them on the  market. The methods and data used to establish the shelf-life are assessed as  part of the regulatory review processes. The United Nations Population Fund  (UNFPA) also requires data supporting shelf-life claims to be submitted as  part of the prequalification process for the procurement of natural rubber latex  male condoms.,天然橡胶乳胶男用避孕套的制造商须根据监管机构的要求，在产品上市前确定其保质期。用于确定保质期的方法和相关数据，将作为监管审查流程的一部分进行评估。此外，联合国人口基金（UNFPA）也要求，在采购天然橡胶乳胶男用避孕套的预审资格认证过程中，提交支持保质期声明的相关数据。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1044-annex9-guidance-on-natural-rubber-latex-male-condom-stability-studies.pdf?sfvrsn=2feeb777_2&download=true,https://www.who.int/publications/m/item/trs1044-annex9
TRS 1044 - Annex 10: WHO/UNFPA technical specification for TCu380A intrauterine device,WHO/UNFPA TCu380A 宫内节育器技术规范,Quality control,30 June 2022,2022-06-30,"This annex contains the World Health Organization (WHO) and United Nations  Population Fund (UNFPA) technical specification for TCu380A intrauterine  device (IUD), which is suitable for bulk procurement of the TCu380A IUD for  use in public sector programmes for family planning.",本附件包含世界卫生组织（WHO）和联合国人口基金（UNFPA）针对TCu380A宫内节育器（IUD）的技术规范，该规范适用于公共部门计划生育项目的TCu380A IUD批量采购。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1044-annex10-technical-specifications-for-tcu380a-intrauterine-device.pdf?sfvrsn=c930269c_2&download=true,https://www.who.int/publications/m/item/trs1044-annex10
TRS 1033 - Annex 6: World Health Organization/United Nations Population Fund Guidance on testing of male latex condoms,世界卫生组织/联合国人口基金关于男性乳胶避孕套检测的指南,Quality control,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033_annex6-who-unfpa-testing-of-male-latex-condoms.pdf?sfvrsn=94358361_1&download=true,https://www.who.int/publications/m/item/annex-6-trs-1033
TRS 1025 - Annex 4: WHO good chromatography practices,WHO GMP,Quality control,20 May 2021,2021-05-20,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex4.pdf?sfvrsn=53f56dbc_4&download=true,https://www.who.int/publications/m/item/trs1025-annex4
TRS 1025 - Annex 1: The International Pharmacopoeia: Procedure for the development of monographs and other texts,国际药典：专论及其他文本的制定程序,Quality control,1 October 2020,2020-10-01,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex1.pdf?sfvrsn=93fa413e_2&download=true,https://www.who.int/publications/m/item/trs1025-annex1
TRS 1025 - Annex 11: UNFPA-WHO specifications for plain lubricants,联合国人口基金-WHO 普通润滑剂规范,Quality control,30 September 2020,2020-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex11.pdf?sfvrsn=3dd1e3bb_2&download=true,https://www.who.int/publications/m/item/trs-1025-annex-11
TRS 1025 - Annex 10: UNFPA-WHO technical specifications for male latex condoms,联合国人口基金-WHO男性乳胶避孕套技术规范,Quality control,30 September 2020,2020-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex10.pdf?sfvrsn=e9a028d1_2&download=true,https://www.who.int/publications/m/item/trs-1025-annex-10
TRS 1010 - Annex 6: WHO good pharmacopoeial practices: Chapter on compounding,WHO GMP：配制章节,Quality control,1 October 2018,2018-10-01,,,https://cdn.who.int/media/docs/default-source/2021-dha-docs/trs1010_annex6_who_good_pharmacopoeial_practices_compounding.pdf?sfvrsn=92ad3957_1&download=true,https://www.who.int/publications/m/item/trs1010-annex6
TRS 1010 - Annex 4: WHO model certificate of analysis,WHO 模式分析证书,Quality control,30 September 2018,2018-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1010_annex4_who_model_certificate_analysis.pdf?sfvrsn=efb98179_1&download=true,https://www.who.int/publications/m/item/trs1010-annex4
TRS 1010 - Annex 7: WHO good pharmacopoeial practices: Chapter on herbal medicines,WHO GMP：草药专章,Quality control,30 September 2018,2018-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1010_annex7_who_good_pharmacopoeial_practices_herbal.pdf?sfvrsn=732a9f2a_1&download=true,https://www.who.int/publications/m/item/trs1010-annex7
TRS 1010 - Annex 5: WHO guidance on testing of “suspect” falsified medicines,WHO关于“可疑”假药检测的指导原则,Quality control,30 September 2018,2018-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1010-annex5-testing-suspect-samples.pdf?sfvrsn=df47cb5_2&download=true,https://www.who.int/publications/m/item/trs1010-annex5
TRS 1010 - Annex 3: WHO considerations for requesting analysis of medicines samples,WHO 要求对药品样品进行分析的考虑因素,Quality control,30 September 2018,2018-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1010_annex3_analysis_medicines_samples.pdf?sfvrsn=368e0484_1&download=true,https://www.who.int/publications/m/item/trs1010-annex3
TRS 1003 - Annex 1: WHO guidelines for selecting marker substances of herbal origin for quality control of herbal medicines,WHO关于选择草药来源的标志物物质以进行草药药品质量控制的指南,Quality control,30 September 2017,2017-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1003-annex1-marker-substances-herbal-medicine-quality-control.pdf?sfvrsn=f4ac0cca_0&download=true,https://www.who.int/publications/m/item/trs1003-annex1
TRS 1003 - Annex 2: The International Pharmacopoeia: Revised concepts and future perspectives,国际药典：修订的概念与未来展望,Quality control,30 September 2017,2017-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1003-annex2-int-ph-revised-concepts.pdf?sfvrsn=d3574af6_0&download=true,https://www.who.int/publications/m/item/trs1003-annex2
TRS 996 - Annex 1: WHO good pharmacopoeial practices,WHO GMP,Quality control,30 September 2016,2016-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs996-annex1-who-good-pharmacopoeial-practices.pdf?sfvrsn=20a98399_8&download=true,https://www.who.int/publications/m/item/trs996-annex1
TRS 992 - Annex 6: WHO recommendations for quality requirements when plant‑derived artemisinin is used as a starting material in the production of antimalarial active pharmaceutical ingredients,WHO关于在抗疟疾原料药生产中使用植物来源青蒿素作为起始物料时的质量要求建议,Quality control,30 September 2015,2015-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs992-annex6.pdf?sfvrsn=48e1e789_2&download=true,https://www.who.int/publications/m/item/trs-992-annex-6
TRS 992 - Annex 2: The International Pharmacopoeia: Updating mechanism for the section on radiopharmaceuticals,国际药典：放射性药物部分的更新机制,Quality control,30 September 2015,2015-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs992-annex2-int-pha-updating-mechanism-radiopharmaceuticals.pdf?sfvrsn=9b73f4f3_0&download=true,https://www.who.int/publications/m/item/trs992-annex2
TRS 981 - Annex 1: Release procedure for International Chemical Reference Substances,国际化学参考物质的放行程序,Quality control,1 October 2013,2013-10-01,,,https://cdn.who.int/media/docs/default-source/medicines/pharmacopoeia/annex1trs-981.pdf?sfvrsn=a8063434_2&download=true,https://www.who.int/publications/m/item/trs981-annex1
TRS 961 - Annex 13: WHO guidelines for preparing a laboratory information file,WHO制定实验室信息文件的指南,Quality control,30 September 2011,2011-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs961-annex13-guidelines-preparing-laboratory-information-file.pdf?sfvrsn=54d1f397_2&download=true,https://www.who.int/publications/m/item/trs961-annex13
TRS 961 - Annex 2: WHO good practices for pharmaceutical microbiology laboratories,WHO药品微生物实验室GMP良好规范,Quality control,30 September 2011,2011-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs961_annex2_goodpractices_pharmaceutical_microbiology_laboratories.pdf?sfvrsn=3fcf27ea_1&download=true,https://www.who.int/publications/m/item/trs961-annex2
"TRS 943 - Annex 3: WHO general guidelines for the establishment, maintenance and distribution of chemical reference substances",WHO关于化学标准物质的建立、维护和分发的通用指南,Quality control,30 September 2007,2007-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs943-annex3-establishmentmaintenance-distribution-chemica-reference-substances.pdf?sfvrsn=71064286_0&download=true,https://www.who.int/publications/m/item/trs943-annex3
TRS 943 - Annex 1: The International Pharmacopoeia: Related substances tests - dosage form monographs guidance notes,国际药典：有关物质检查——剂型专论指导性说明,Quality control,30 September 2007,2007-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs943-annex1-int-pha-related-substances.pdf?sfvrsn=6e408a40_0&download=true,https://www.who.int/publications/m/item/trs943-annex1
TRS 908 - Annex 1: WHO recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products,WHO关于通过药品传播动物源性海绵状脑病病原体风险的建议,Quality control,1 October 2002,2002-10-01,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs908-annex1-animal-spongiform-encephalopathy-agents.pdf?sfvrsn=3a89f635_0&download=true,https://www.who.int/publications/m/item/trs908-annex1
"Basic tests for drugs: pharmaceutical substances, medicinal plant materials and dosage forms - 1998",药品基本检验：原料药、 medicinal plant materials 和制剂 - 1998,Quality control,12 August 1998,1998-08-12,This manual has been designed to be used on conjunction with the two earlier WHO  publications:,本手册旨在与WHO此前的两份出版物配合使用：,https://iris.who.int/bitstream/handle/10665/42020/9241545135.pdf?sequence=1,https://www.who.int/publications/i/item/9241545135
Quality control methods for medicinal plant materials,药用植物原料的GMP质量控制方法,Quality control,1 May 1998,1998-05-01,,,https://iris.who.int/bitstream/handle/10665/41986/9241545100.pdf?sequence=1,https://www.who.int/publications/i/item/9241545100
TRS 1060 - Annex 8: Collaborative registration procedure between WHO and national regulatory authorities in the assessment and accelerated national registration of WHO-prequalified vector control products,世界卫生组织与各国监管机构在评估和加快WHO预认证的病媒控制产品国家注册方面的合作注册程序,Regulatory standards,15 April 2025,2025-04-15,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/annex-8_collaborative-registration-procedure-between-who-and-nras-vector-control.pdf?sfvrsn=1a3cf392_5&download=true,https://www.who.int/publications/m/item/trs-1060---annex-8--collaborative-registration-procedure-between-who-and-national-regulatory-authorities-in-the-assessment-and-accelerated-national-registration-of-who-prequalified-vector-control-products
TRs 1060 - Annex 7: Good practices of national regulatory authorities in implementing the collaborative registration procedures for medical products,国家药品监管机构实施药品协同注册程序的良好实践,Regulatory standards,15 April 2025,2025-04-15,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/annex-7_good-practices-of-nras-in-implementing-the-collaborative-registration-procedures-for-medical-products.pdf?sfvrsn=15735b6f_3&download=true,https://www.who.int/publications/m/item/trs-1060---annex-7--good-practices-of-national-regulatory-authorities-in-implementing-the-collaborative-registration-procedures-for-medical-products
"TRS 1060 - Annex 5: WHO Biowaiver List: proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms",WHO生物豁免清单：关于对WHO基本药物示范清单中速释固体口服制剂免除体内生物等效性要求的建议,Regulatory standards,15 April 2025,2025-04-15,The aim of the WHO Biowaiver List is to enable an informed decision as to whether or not a waiver from in vivo bioequivalence studies could be granted safely according to the WHO guideline on Biopharmaceutics Classification System based biowaivers (1).,WHO生物豁免清单的目的是根据WHO关于基于生物药剂学分类系统进行的生物豁免指南（1），帮助决策是否可以安全地豁免体内生物等效性研究。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/annex-5_who-biowaiver-list.pdf?sfvrsn=ae876a0_3&download=true,https://www.who.int/publications/m/item/trs-1060---annex-5--who-biowaiver-list--proposal-to-waive-in-vivo-bioequivalence-requirements-for-who-model-list-of-essential-medicines-immediate-release--solid-oral-dosage-forms
TRS 1060 - Annex 6: Guideline on bioanalytical method validation and study sample analysis,生物分析方法验证与研究样品分析指南,Regulatory standards,15 April 2025,2025-04-15,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/annex-6_guideline-on-bioanalytical-method-validation-and-study-sample-analysis.pdf?sfvrsn=4fc96250_3&download=true,https://www.who.int/publications/m/item/trs-1060---annex-6--guideline-on-bioanalytical-method-validation-and-study-sample-analysis
TRS 1052 - Annex 8: Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability,多源（仿制药）药品：关于建立可互换性的注册要求指南,Regulatory standards,26 April 2024,2024-04-26,"These guidelines provide recommendations to regulatory authorities when defining requirements for approval of multisource (generic) pharmaceutical products in their respective countries. The guidance provides appropriate in vivo and in vitro requirements to assure interchangeability of the multisource product without compromising the safety, quality and efficacy of the pharmaceutical product.",这些指南为监管机构在各自国家制定多源（仿制）药品的批准要求时提供了建议。该指南提出了适当的体内和体外要求，以确保多源产品的可互换性，同时不损害药品的安全性、质量和有效性。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1052_annex8.pdf?sfvrsn=277ee0f8_5&download=true,https://www.who.int/publications/m/item/trs-1052---annex-8--multisource-(generic)-pharmaceutical-products--guidelines-on-registration-requirements-to-establish-interchangeability
TRS 1052 - Annex 7: WHO guideline on Biopharmaceutics ClassificationSystem-based biowaivers,WHO基于生物药剂学分类系统的一致性豁免指南,Regulatory standards,26 April 2024,2024-04-26,The WHO guideline on Biopharmaceutics Classification System-based biowaivers will supersede the BCS-based biowaiver section of the WHO Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability (1). The purpose of this document is to provide recommendations to support the biopharmaceutics classification of active pharmaceutical ingredients (APIs) and the BCS-based biowaiver of bioequivalence studies for finished pharmaceutical products (FPPs).,WHO基于生物药剂学分类系统的一致性豁免指南将取代WHO多源（仿制）药品：关于确立可互换性的注册要求指南（1）中基于BCS的一致性豁免部分。本文旨在提供相关建议，以支持原料药的生物药剂学分类，以及基于BCS的成品药生物等效性研究一致性豁免。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1052_annex7.pdf?sfvrsn=8f3d4497_4&download=true,https://www.who.int/publications/m/item/trs-1052---annex-7--who-guideline-on-biopharmaceutics-classificationsystem-based-biowaivers
"TRS 1052 - Annex 6: WHO Biowaiver List: proposal to waive in vivobioequivalence requirements for WHO Model Listof Essential Medicines immediate-release, solid oraldosage forms",WHO生物豁免清单：建议对WHO基本药物标准清单中的速释固体口服剂型免除体内生物等效性要求,Regulatory standards,26 April 2024,2024-04-26,"The WHO solubility classification, also referred to as the WHO Biowaiver List, is a tool for national regulatory authorities and pharmaceutical manufacturing companies, suggesting medical products that are eligible for a waiver from in vivo bioequivalence studies, which are usually necessary to establish the therapeutic equivalence with the originator (comparator). For exemption from an in vivo bioequivalence study, an immediate-release, multisource (generic) product should exhibit very rapid or rapid in vitro dissolution characteristics that are comparable to those of the reference product. A risk-based evaluation should also account for the excipients used in the formulation of the finished pharmaceutical product.",WHO溶解度分类，也被称为WHO生物豁免清单，是供各国监管机构和制药生产企业使用的一种工具，用于推荐可免除体内生物等效性研究的药品。通常，此类研究是确立仿制药（参比制剂）与原研药（对照药）治疗等效性的必要步骤。为获得体内生物等效性研究的豁免，速释型多来源（仿制）产品应表现出与参比产品相当的极快或快速体外溶出特性。此外，基于风险的评估还应考虑成品制剂中所使用的辅料。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1052_annex6.pdf?sfvrsn=2252177e_4&download=true,https://www.who.int/publications/m/item/trs-1052---annex-6--who-biowaiver-list--proposal-to-waive-in-vivobioequivalence-requirements-for-who-model-listof-essential-medicines-immediate-release--solid-oraldosage-forms
TRS 1052 - Annex 5: WHO/UNFPA female condom generic specification,WHO/UNFPA 女性安全套通用规范,Regulatory standards,26 April 2024,2024-04-26,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs1052_annex5.pdf?sfvrsn=81780e4d_4&download=true,https://www.who.int/publications/m/item/trs-1052---annex-5--who-unfpa-female-condom-generic-specification
TRS 1044 - Annex 9: WHO/UNFPA guidance on natural rubber latex male condom stability studies,WHO/UNFPA 关于天然橡胶乳胶男用安全套稳定性研究的指导原则,Regulatory standards,30 September 2022,2022-09-30,Manufacturers of natural rubber latex male condoms are required by regulatory  bodies to establish the shelf-life of their products prior to placing them on the  market. The methods and data used to establish the shelf-life are assessed as  part of the regulatory review processes. The United Nations Population Fund  (UNFPA) also requires data supporting shelf-life claims to be submitted as  part of the prequalification process for the procurement of natural rubber latex  male condoms.,天然橡胶乳胶男用避孕套的制造商须根据监管机构的要求，在产品上市前确定其保质期。用于确定保质期的方法和相关数据，将作为监管审查流程的一部分进行评估。此外，联合国人口基金（UNFPA）也要求，在采购天然橡胶乳胶男用避孕套的预审资格认证过程中，提交支持保质期声明的相关数据。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1044-annex9-guidance-on-natural-rubber-latex-male-condom-stability-studies.pdf?sfvrsn=2feeb777_2&download=true,https://www.who.int/publications/m/item/trs1044-annex9
TRS 1044 - Annex 6: WHO good practices for research and development facilities of pharmaceutical products,WHO 制药产品研发机构的 GMP 实践,Regulatory standards,30 September 2022,2022-09-30,"This annex contains the World Health Organization (WHO) and United Nations  Population Fund (UNFPA) technical specification for TCu380A intrauterine  device (IUD), which is suitable for bulk procurement of the TCu380A IUD for  use in public sector programmes for family planning.",本附件包含世界卫生组织（WHO）和联合国人口基金（UNFPA）针对TCu380A宫内节育器（IUD）的技术规范，该规范适用于公共部门计划生育项目的TCu380A IUD批量采购。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1044-annex6-good-practices-for-research-and-dev-facilities-of-pharmaceutical-products.pdf?sfvrsn=e50d092f_3&download=true,https://www.who.int/publications/m/item/trs1044-annex6
TRS 1044 - Annex 10: WHO/UNFPA technical specification for TCu380A intrauterine device,WHO/UNFPA TCu380A型宫内节育器技术规范,Regulatory standards,30 June 2022,2022-06-30,"This annex contains the World Health Organization (WHO) and United Nations  Population Fund (UNFPA) technical specification for TCu380A intrauterine  device (IUD), which is suitable for bulk procurement of the TCu380A IUD for  use in public sector programmes for family planning.",本附件包含世界卫生组织（WHO）和联合国人口基金（UNFPA）针对TCu380A宫内节育器（IUD）的技术规范，适用于公共部门计划生育项目的TCu380A IUD批量采购。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1044-annex10-technical-specifications-for-tcu380a-intrauterine-device.pdf?sfvrsn=c930269c_2&download=true,https://www.who.int/publications/m/item/trs1044-annex10
TRS 1033 - Annex 7: World Health Organization/United Nations Population Fund guidance on conducting post-market surveillance of condoms,世界卫生组织/联合国人口基金关于开展避孕套上市后监测的指南,Regulatory standards,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033-annex7-who-unfpa-pms-for-condoms.pdf?sfvrsn=93e44a84_1&download=true,https://www.who.int/publications/m/item/annex-7-trs-1033
TRS 1033 - Annex 9: Guidelines on the implementation of the WHO Certification Scheme on the quality of pharmaceutical products moving in international commerce,世界卫生组织（WHO）关于国际药品贸易中药品质量认证计划实施的指南,Regulatory standards,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033_annex9_guidelines-on-implementation-of-cpp.pdf?sfvrsn=c40c033b_1&download=true,https://www.who.int/publications/m/item/annex-9-trs-1033
TRS 1033 - Annex 5: World Health Organization/United Nations Population Fund Recommendations for condom storage and shipping temperatures,世界卫生组织/联合国人口基金关于安全套储存和运输温度的建议,Regulatory standards,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033_annex5-who-unfpa-storage-and-shipping-temperatures-for-condoms.pdf?sfvrsn=dd177d11_1&download=true,https://www.who.int/publications/m/item/annex-5-trs-1033
TRS 1033 - Annex 6: World Health Organization/United Nations Population Fund Guidance on testing of male latex condoms,世界卫生组织/联合国人口基金关于男性乳胶避孕套检测的指南,Regulatory standards,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033_annex6-who-unfpa-testing-of-male-latex-condoms.pdf?sfvrsn=94358361_1&download=true,https://www.who.int/publications/m/item/annex-6-trs-1033
TRS 1033 - Annex 11: Good regulatory practices in the regulation of medical products,药品监管中的良好监管规范,Regulatory standards,9 October 2021,2021-10-09,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033-annex11-good-practices-for-regulation-of-medical-products.pdf?sfvrsn=cf97ea1d_6&download=true,https://www.who.int/publications/m/item/annex-11-trs-1033
TRS 1033 - Annex 10: Good reliance practices in the regulation of medical products: high level principles and considerations,医疗器械产品监管中的良好GMP实践：高级别原则与考量,Regulatory standards,9 October 2021,2021-10-09,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/grelp-annex-10-trs-1033/trs1033_annex10-good-reliance-practices.pdf?sfvrsn=dd5502cb_17&download=true,https://www.who.int/publications/m/item/annex-10-trs-1033
"TRS 953 - Annex 2, Appendix 1: Stability testing of active pharmaceutical ingredients and finished pharmaceutical products: Stability conditions for WHO Member States by Region",原料药和成品药品的稳定性测试：按区域划分的WHO成员国稳定性条件,Regulatory standards,9 March 2021,2021-03-09,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs953-annex2-appendix1-stability-conditions-table-2018.pdf?sfvrsn=74032aec_12&download=true,https://www.who.int/publications/m/item/trs953-annex2-appendix1
TRS 1025 - Annex 2: IAEA - WHO good manufacturing practices for radiopharmaceutical products,国际原子能机构 - WHO 放射性药物产品的 GMP,Regulatory standards,30 September 2020,2020-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex2.pdf?sfvrsn=7aceb0c1_6&download=true,https://www.who.int/publications/m/item/trs1025-annex2
TRS 1025 - Annex 11: UNFPA-WHO specifications for plain lubricants,联合国人口基金-WHO 普通润滑剂规范,Regulatory standards,30 September 2020,2020-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex11.pdf?sfvrsn=3dd1e3bb_2&download=true,https://www.who.int/publications/m/item/trs-1025-annex-11
TRS 1025 - Annex 10: UNFPA-WHO technical specifications for male latex condoms,联合国人口基金-WHO男性乳胶避孕套技术规范,Regulatory standards,30 September 2020,2020-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/trs1025/trs1025-annex10.pdf?sfvrsn=e9a028d1_2&download=true,https://www.who.int/publications/m/item/trs-1025-annex-10
TRS 1025 - Annex 13: WHO guideline on the implementation of quality management systems for national regulatory authorities,WHO关于国家监管机构实施质量管理体系的指南,Regulatory standards,20 April 2020,2020-04-20,"The aim of this guideline is to assist NRAs to develop, implement and improve their QMSs, based on principles from International Organization for Standardization (ISO) document ISO 9001 standard requirements (5). It provides recommendations on what NRAs should implement and maintain under each QMS to effectively and efficiently support the execution of NRA functions as mandated by national laws and regulations. The guideline is expected to promote consistency in regulatory practices within and across NRAs, to facilitate harmonization, mutual reliance and recognition mechanisms among Member States.",本指南旨在帮助国家监管机构（NRA）根据国际标准化组织（ISO）文件ISO 9001标准要求中的原则，制定、实施并改进其质量管理体系（QMS）（5）。指南针对每个质量管理体系，提出了NRA应实施和保持的具体内容建议，以有效且高效地支持国家法律法规所赋予的NRA职能。预计该指南将促进各NRA内部及不同NRA之间的监管实践一致性，从而推动成员国间协调一致、相互信任与认可机制的建立。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/prequalification/trs1025-annex13.pdf?sfvrsn=2fe3b8d_18&download=true,https://www.who.int/publications/m/item/trs-1025-annex-13-qms-nra
TRS 1019 - Annex 5: Guidelines on import procedures for medical products,医疗产品进口程序指南,Regulatory standards,10 October 2019,2019-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs1019-annex5-who-guidelines-on-import-procedures-for-medical-products.pdf?sfvrsn=ef223e14_2&download=true,https://www.who.int/publications/m/item/annex-5-trs-1019
TRS 1019 - Annex 6: Good practices of national regulatory authorities in implementing the collaborative registration procedures for medical products,国家药品监管机构实施药品协同注册程序的良好实践,Regulatory standards,10 October 2019,2019-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1019-annex6.pdf?sfvrsn=f839be63_2&download=true,https://www.who.int/publications/m/item/annex-6-trs-1019
TRS 1019 - Annex 4: Protocol to conduct equilibrium solubility experiments for the purpose of Biopharmaceutics Classification System-based classification of active pharmaceutical ingredients for biowaiver,用于基于生物药剂学分类系统对原料药进行生物豁免分类的平衡溶解度实验规程,Regulatory standards,10 October 2019,2019-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1019-annex4-classification-system-based-classification-of-active-pharmaceutical-ingredients-for-biowaiver.pdf?sfvrsn=7ee2de7d_2&download=true,https://www.who.int/publications/m/item/annex-4-trs-1019
TRS 1010 - Annex 11: Collaborative procedure in the assessment and accelerated national registration of pharmaceutical products and vaccines approved by stringent regulatory authorities,药品和疫苗经严格监管机构批准后的评估与加速国家注册的协作程序,Regulatory standards,10 October 2018,2018-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1010-annex11.pdf?sfvrsn=b7c8b9c1_2&download=true,https://www.who.int/publications/m/item/annex-11-trs-1010
TRS 1010 - Annex 10: WHO guidelines on stability testing of active pharmaceutical ingredients and finished pharmaceutical products,WHO关于原料药和成品药稳定性试验的指南,Regulatory standards,30 September 2018,2018-09-30,"The guidance on Stability testing of active pharmaceutical ingredients and  finished pharmaceutical products was published as Annex 2 in the World Health  Organization (WHO) Technical Report Series, No. 953, 2009 (1).  The aim of these regulatory guidelines is to outline the core stability data  package required for registration of active pharmaceutical ingredients (APIs) and  finished pharmaceutical products (FPPs), replacing the previous WHO guidelines  in this area. The guidelines cross-refer to the series of related documents published  by the International Council for Harmonisation of Technical Requirements for  Pharmaceuticals for Human Use (ICH) (2) and other WHO guidelines.  It was recommended that at the time of their publication these guidelines  should also be applied to products that are already being marketed, making  allowance for an appropriate transition period, for example, they could become  applicable upon re-registration or upon re-evaluation.  The 2009 guidance not only followed the usual consultation process, but  it was also the result of numerous discussions with the various regulatory forums,  including ICH. As a result, the ICH parties withdrew one of their guidance texts  (Q1F) and published the following text on their website:",关于原料药和成品药稳定性试验的指导原则已于2009年作为世界卫生组织（WHO）技术报告系列第953号附件2发布（1）。这些法规性指导原则旨在概述注册原料药（API）和成品药（FPP）所需的核心稳定性数据包，以取代此前WHO在该领域的相关指南。这些指导原则与国际人用药品注册技术要求协调会（ICH）发布的系列相关文件（2）及其他WHO指南相互参照。建议在指南发布时，也应将其适用于已上市的产品，同时适当预留过渡期，例如可在重新注册或重新评估时开始实施。2009年的指导原则不仅遵循了常规的咨询流程，更是与包括ICH在内的多个监管机构论坛进行了多次深入讨论的结果。因此，ICH各参与方撤回了其原有的一份指导性文件（Q1F），并在其网站上发布了以下文本：,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1010-annex10-who-stability-testing-of-active-pharmaceutical-ingredients.pdf?sfvrsn=7cb7a4c9_4&download=true,https://www.who.int/publications/m/item/trs1010-annex10
"TRS 1010 - Annex 9: WHO good practices for desk assessment of compliance with good manufacturing practices, good laboratory practices and good clinical practices for medical products regulatory decisions",WHO药品监管决策中医疗产品GMP、GLP和GCP合规性桌面评估的良好实践,Regulatory standards,30 September 2018,2018-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/trs1010-annex9--desk-assessment.pdf?sfvrsn=3e2b1a_2&download=true,https://www.who.int/publications/m/item/trs1010-annex9
TRS 1003 - Annex 4: WHO Global Model Regulatory Framework for Medical Devices including in vitro diagnostic medical devices,WHO全球医疗器械监管框架模型，包括体外诊断医疗器械,Regulatory standards,10 October 2017,2017-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1003-annex4-who-model-regulatory-framework-medical-devices.pdf?sfvrsn=66924772_2&download=true,https://www.who.int/publications/m/item/annex-4-trs-1003
"TRS 1003, Annex 5: General background notes on the list of international comparator pharmaceutical products",国际参比药品清单的一般背景说明,Regulatory standards,10 October 2017,2017-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs1003-annex5-who-list-international-comparator.pdf?sfvrsn=8ff132b2_2&download=true,https://www.who.int/publications/m/item/annex-5-trs-1003
TRS 966 - Annex 9: Guidance for organizations performing in vivo bioequivalence studies,开展体内生物等效性研究的机构指南,Regulatory standards,10 October 2016,2016-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs966-annex9-invivo-bioequivalence-studies.pdf?sfvrsn=510cfeec_2&download=true,https://www.who.int/publications/m/item/annex-9-trs-966
TRS 966 - Annex 10: WHO general guidance on variations to multisource pharmaceutical products,WHO 关于多源药品变更的总体指南,Regulatory standards,30 September 2016,2016-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs966-annex10.pdf?sfvrsn=5d94f486_2&download=true,https://www.who.int/publications/m/item/trs966-annex10
TRS 992 - Annex 9: Good review practices: guidelines for national and regional regulatory authorities,良好评审规范：面向国家和区域监管机构的指南,Regulatory standards,10 October 2015,2015-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs992-annex9.pdf?sfvrsn=f94751de_2&download=true,https://www.who.int/publications/m/item/annex-9-trs-992
"TRS 992, Annex 8 - Guidance on the selection of comparator pharmaceutical products for equivalence assessment of interchangeable multisource (generic) products",TRS 992，附件8 - 关于选择对照药品以评估可互换多源（仿制药）产品等效性的指南,Regulatory standards,10 October 2015,2015-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs992-annex8-who-comparators-multisource.pdf?sfvrsn=c5116e6_2&download=true,https://www.who.int/publications/m/item/annex-8-trs-992
TRS 992 - Annex 6: WHO recommendations for quality requirements when plant‑derived artemisinin is used as a starting material in the production of antimalarial active pharmaceutical ingredients,WHO关于植物来源青蒿素用作抗疟疾原料药生产起始物料时的质量要求建议,Regulatory standards,30 September 2015,2015-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/trs992-annex6.pdf?sfvrsn=48e1e789_2&download=true,https://www.who.int/publications/m/item/trs-992-annex-6
TRS 986 - Annex 6: Guidelines on submission of documentation for a multisource (generic) finished pharmaceutical product: quality part,多源（仿制）成品制药产品的文件提交指南：质量部分,Regulatory standards,10 October 2014,2014-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs986-annex6.pdf?sfvrsn=ec67d04f_2&download=true,https://www.who.int/publications/m/item/annex-6-trs-986
TRS 981 - Annex 2: WHO guidelines on quality risk management,WHO关于质量风险管理的指南,Regulatory standards,25 January 2013,2013-01-25,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs981-annex2-who-quality-risk-management.pdf?sfvrsn=2fa44bc4_2&download=true,https://www.who.int/publications/m/item/trs981-annex2
TRS 961 - Annex 14: WHO guidelines for drafting a site master file,WHO起草现场主文件的指南,Regulatory standards,31 October 2011,2011-10-31,The aim of these explanatory notes is to guide the manufacturer of medicinal  products in the preparation of an SMF that is useful to the regulatory  authority in planning and conducting GMP inspections.,本说明旨在指导药品生产商编制一份SMF，以帮助监管机构规划和实施GMP检查。,https://cdn.who.int/media/docs/default-source/medicines/who-technical-report-series-who-expert-committee-on-specifications-for-pharmaceutical-preparations/who-guidelines-for-drafting-a-site-master-filee834ef01-0ebe-400d-9130-daff614884d8.pdf?sfvrsn=89e9986b_1&download=true,https://www.who.int/publications/m/item/trs961-annex14
TRS 957 - Annex 7: WHO guidelines for the preparation of a contract research organization master file,WHO关于合同研究组织主文件编制的指南,Regulatory standards,30 September 2010,2010-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs957-annex7-guidelinespreparationcontractresearchorgmasterfile.pdf?sfvrsn=958aef39_2&download=true,https://www.who.int/publications/m/item/trs-957-annex-7
TRS 948 - Annex 4: Guidelines on active pharmaceutical ingredient master file procedure,活性药物成分主文件程序指南,Regulatory standards,10 October 2008,2008-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs948-annex5-guidelinesactivepharmaceuticalingredient.pdf?sfvrsn=c64a180f_2&download=true,https://www.who.int/publications/m/item/annex-4-trs-948
TRS 948 - Annex 5: International Nonproprietary Names for biological and biotechnological substances: a review,生物制品和生物技术产品的国际非专利名称：综述,Regulatory standards,9 October 2008,2008-10-09,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs948-annex5-inn-for-biological-and-biotech-products.pdf?sfvrsn=ac2c58c_1&download=true,https://www.who.int/publications/m/item/annex-5-trs-948
TRS 929 - Annex 4: WHO guidelines for sampling of pharmaceutical products and related materials,WHO药品及相关物料取样指南,Regulatory standards,10 October 2005,2005-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs929-annex4-guidelinessamplingpharmproducts.pdf?sfvrsn=c47a0070_1&download=true,https://www.who.int/publications/m/item/annex-4-trs-929
TRS 929 - Annex 5: Guidelines for registration of fixed-dose combination medicinal products,固定剂量复方药物注册指南,Regulatory standards,9 October 2005,2005-10-09,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs929-annex5-guidelines-for-registration-of-fixed-dose-combination-medical-products.pdf?sfvrsn=99717b5b_4&download=true,https://www.who.int/publications/m/item/annex-5-trs-929
TRS 917 - Annex 3: WHO pharmaceutical starting materials certification scheme (SMACS): guidelines on implementation,WHO原料药认证计划（SMACS）：实施指南,Regulatory standards,10 October 2003,2003-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs917-annex3-certification-scheme-implementation.pdf?sfvrsn=dbdf5179_2&download=true,https://www.who.int/publications/m/item/annex-3-trs-917
TRS 902 - Annex 9: Guidelines on packaging for pharmaceutical products,药品包装指南,Regulatory standards,10 October 2002,2002-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/regulatory-standards/trs902-annex9.pdf?sfvrsn=82b4c57d_2&download=true,https://www.who.int/publications/m/item/annex-9-trs-902
WHO List of International Comparator Products,WHO国际参比产品清单,Regulatory standards,11 December 2024,2024-12-11,"The list of international comparator products provides tabulated information about pharmaceutical products on the World Health Organization (WHO) Model List of Essential Medicines (EML), specific finished pharmaceutical products that can be selected as comparators (column headed “International comparator product”) and the markets where the product’s quality, safety and efficacy is considered as best documented (column headed “Market”). This list is for identifying comparator products for equivalence assessment of interchangeable multisource (generic) products. Comparator products recommended by the WHO Prequalification Team – Medicines (PQTm) are included in the list of international comparator products (column headed “PQ comparator product”). The list is compiled based on data publicly available and information provided by medicines regulatory authorities and manufacturers.",国际参比产品清单提供了世界卫生组织（WHO）基本药物标准清单（EML）中药品的汇总信息，列出了可作为参比品选择的具体成品药品种（栏目标题为“国际参比产品”），以及这些产品在哪些市场上的质量、安全性和有效性被认为有最充分的文献证据支持（栏目标题为“市场”）。该清单旨在帮助确定可互换的多来源（仿制）产品的等效性评估所用的参比品。由WHO药品预审评团队——药品（PQTm）推荐的参比产品已被纳入国际参比产品清单（栏目标题为“PQ参比产品”）。本清单依据公开可得的数据，以及药品监管机构和生产商提供的信息编制而成。,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/who_mhp_hps_tss_nsp_2024.2.xlsx?sfvrsn=efb0f02_3&download=true,https://www.who.int/publications/m/item/the-list-of-international-comparator-products
"TRS 1025 - Annex 9: World Health Organization/United Nations Population Fund Prequalification Programme guidance for contraceptive devices: male latex condoms, female condoms and intrauterine devices",世界卫生组织/联合国人口基金预审方案：避孕器械指南——男用乳胶避孕套、女用避孕套和宫内节育器,Prequalification,20 April 2020,2020-04-20,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/prequalification/trs1025-annex9.pdf?sfvrsn=ef30a3e6_1&download=true,https://www.who.int/publications/m/item/trs-1025-annex-9
"TRS 1003 - Annex 3: Prequalification of quality control laboratories: procedure for assessing the acceptability, in principle, of quality control laboratories for use by United Nations agencies",质量控制实验室的预认证：评估联合国机构拟使用的质量控制实验室原则上可接受性的程序,Prequalification,10 October 2017,2017-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/prequalification/trs1003-annex3-quality-control-laboratories.pdf?sfvrsn=c07d6468_2&download=true,https://www.who.int/publications/m/item/annex-3-trs-1003
TRS 996 - Annex 8: Collaborative procedure between WHO Prequalification Team and national regulatory authorities in the assessment and accelerated national registration of WHO-prequalified pharmaceutical products and vaccines,世界卫生组织预认证团队与国家监管机构之间的协作程序，用于评估并加速WHO预认证药品和疫苗的国家注册,Prequalification,17 November 2016,2016-11-17,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/prequalification/trs996-annex08-crp-pq.pdf?sfvrsn=791d2c89_4&download=true,https://www.who.int/publications/m/item/trs996-annex08-crp-pq
TRS 986 - Annex 5: Guidelines on submission of documentation for prequalification of finished pharmaceutical products approved by stringent regulatory authorities,经严格监管机构批准的成品药预审资格文件提交指南,Prequalification,9 October 2014,2014-10-09,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs986-annex5.pdf?sfvrsn=f1246206_1&download=true,https://www.who.int/publications/m/item/annex-5-trs-986
TRS 981 - Annex 3: WHO guidelines on variations to a prequalified product,WHO关于预审产品变更的指南,Prequalification,10 October 2013,2013-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/prequalification/trs981-annex3-who-variations-prequalified-product.pdf?sfvrsn=809e81b_2&download=true,https://www.who.int/publications/m/item/annex-3-trs-981
TRS 970 - Annex 4: Guidelines on submission of documentation for a multisource (generic) finished pharmaceutical product for the WHO Prequalification of Medicines Programme: quality part,多源（仿制）成品药品向WHO药品预认证计划提交文件的指南：质量部分,Prequalification,10 October 2012,2012-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/prequalification/trs970-annex4--multisource-prequal-quality-partpdf.pdf?sfvrsn=70912c7a_2&download=true,https://www.who.int/publications/m/item/annex-4-trs-970
TRS 961 - Annex 10: Procedure for prequalification of pharmaceutical products,药品产品预审定程序,Prequalification,10 October 2011,2011-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/prequalification/trs961-annex10-who-procedure-prequalification.pdf?sfvrsn=85029f47_2&download=true,https://www.who.int/publications/m/item/annex-10-trs-961
TRS 957 - Annex 6: Guidelines on the requalification of prequalified dossiers,预审资格档案重新认定指南,Prequalification,10 October 2010,2010-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/prequalification/trs957-annex6-who-requalification-prequalified-dossiers.pdf?sfvrsn=c9bbc6e4_2&download=true,https://www.who.int/publications/m/item/annex-6-trs-957
"TRS 953 - Annex 4: Procedure for assessing the acceptability, in principle, of active pharmaceutical ingredients for use in pharmaceutical products",评估原料药用于药品的可接受性原则程序,Prequalification,10 October 2009,2009-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/prequalification/trs953-annex4-procedureassessingacceptabilityprincipleactivepharmaceutical.pdf?sfvrsn=f43b8475_2&download=true,https://www.who.int/publications/m/item/annex-4-trs-953
TRS 1033 - Annex 4: WHO Guideline on data integrity,WHO GMP 数据完整性指南,Quality Assurance,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033-annex4-guideline-on-data-integrity.pdf?sfvrsn=6218a4e6_4&download=true,https://www.who.int/publications/m/item/annex-4-trs-1033
TRS 1033 - Annex 2: Points to consider when including Health-Based Exposure Limits (HBELs) in cleaning validation,在清洁验证中纳入基于健康的暴露限值（HBELs）时需考虑的要点,Quality Assurance,10 October 2021,2021-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/inspections/trs1033-annex2-points-to-consider-when-incl-hbels-in-cleaning-validation.pdf?sfvrsn=5ee0cd8a_1&download=true,https://www.who.int/publications/m/item/annex-2-trs-1033
TRS 986 - Appendix 6: Interagency finished pharmaceutical product questionnaire,跨机构成品药品问卷,Quality Assurance,17 February 2021,2021-02-17,,,https://cdn.who.int/media/docs/default-source/procurement/iapq-template.pdf?sfvrsn=de076515_1&download=true,https://www.who.int/publications/m/item/interagency-finished-pharmaceutical-product-questionnaire
TRS 1019 - Annex 3: Good manufacturing practices: guidelines on validation,GMP：验证指南,Quality Assurance,25 January 2019,2019-01-25,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1019-annex3-gmp-validation.pdf?sfvrsn=9440a5c_0&download=true,https://www.who.int/publications/m/item/trs1019-annex3
TRS 996 - Annex 6: WHO good trade and distribution practices for pharmaceutical starting materials,WHO药品原料药良好贸易与分销规范,Quality Assurance,10 October 2016,2016-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs996-annex06-good-trade-and-distribution-practice-for-starting-materials914a3c92-e15d-420d-859a-34f666a6c659.pdf?sfvrsn=71e466ca_2&download=true,https://www.who.int/publications/m/item/annex-6-trs-996
TRS 966 - Annex 7: Guidelines on the conduct of surveys of the quality of medicines,药品质量调查指南,Quality Assurance,10 October 2016,2016-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs966-annex7-who-guidelines-on-the-conduct-of-surveys-of-the-quality-of-medicines.pdf?sfvrsn=4dbb5519_2&download=true,https://www.who.int/publications/m/item/Annex-7-trs-no-966
Guidelines on the conduct of surveys of the quality of medicines - QAS/15.630,药品质量调查指南 - QAS/15.630,Quality Assurance,30 June 2015,2015-06-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/current-projects/guidelines-on-medicines-quality-surveys-qas15-630-30062015.pdf?sfvrsn=4869e295_2&download=true,https://www.who.int/publications/m/item/qas-15.630
TRS 986 - Annex 4: Assessment tool based on the model quality assurance system for procurement agencies: aide-memoire for inspection,基于采购机构模型质量保证体系的评估工具：检查备忘录,Quality Assurance,10 October 2014,2014-10-10,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs986-annex4-assessment-tool-based-on-the-model-quality-assurance-system.pdf?sfvrsn=d4c03f00_7&download=true,https://www.who.int/publications/m/item/annex4-trs986-eng
TRS 986 - Annex 3: WHO model quality assurance system for procurement agencies,WHO采购机构GMP质量保证体系范本,Quality Assurance,30 September 2014,2014-09-30,,,https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs986-annex3-who-model-quality-assurance-system-for-procurement-agencies.pdf?sfvrsn=4baca576_4&download=true,https://www.who.int/publications/m/item/trs-986-annex-3
